Reviva Pharmaceuticals Holdings Inc (RVPH)
1.66
-0.05
(-2.92%)
USD |
NASDAQ |
May 17, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Cash from Financing (Quarterly): 0.332M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.332M |
| December 31, 2023 | 27.27M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 5.213M |
| March 31, 2023 | 0.6871M |
| December 31, 2022 | 0.0186M |
| September 30, 2022 | 7.774M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0001M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0985M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 31.50M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 0.8741M |
| June 30, 2020 | 0.38M |
| March 31, 2020 | 0.23M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
31.50M
Maximum
Jun 2021
5.042M
Average
0.332M
Median
Mar 2024
Cash from Financing (Quarterly) Benchmarks
| AbbVie Inc | 10.82B |
| ABVC BioPharma Inc | 0.0874M |
| Sutro Biopharma Inc | -3.429M |
| Flora Growth Corp | 0.704M |
| Journey Medical Corp | 1.637M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.73M |
| Free Cash Flow | -32.10M |
| Free Cash Flow Per Share (Quarterly) | -0.3923 |
| Free Cash Flow Yield | -74.48% |